Clinical trial Recruiting at 2 sites Observational Ages 20 and up

Evaluating the Zimmer Biomet Shoulder Replacement System

Official title: Zimmer Biomet Shoulder Arthroplasty Long-term Post Market Clinical Follow-up Study

Run by Zimmer Biomet · NCT06920459 · Data updated 2026-11-12

This study is testing how safe and effective the Zimmer Biomet Shoulder Replacement System is for people getting shoulder surgery, looking at their pain, movement, and quality of life over two years.

Quick facts

Study typeObservational
Ages20 Years and up
SexAll
Enrollment50 (estimated)
SponsorZimmer Biomet
Industry-sponsored
Locations2 sites (Pforzheim and 1 other locations)
StatusRecruiting
StartedApril 29, 2025
Main results expectedJune 2029
Study endsJune 2037
Registry record updatedJune 8, 2026
Trial IDNCT06920459 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 20 and older who require shoulder arthroplasty due to conditions like osteoarthritis, rheumatoid arthritis, or shoulder fractures.

Probably not a fit

Patients who are unwilling or unable to provide consent or have conditions that may pose undue risk are unlikely to benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter, prospective observational study aims to assess the safety and performance of the Zimmer Biomet Shoulder Arthroplasty systems in patients undergoing primary anatomic shoulder arthroplasty. The study will monitor adverse events and evaluate improvements in pain, functional performance, quality of life, and radiographic parameters over a two-year period. The primary endpoint focuses on the American Shoulder and Elbow Surgeons (ASES) shoulder score, while secondary endpoints will further assess safety and overall patient outcomes.

Why it matters

Potential benefit: If successful, this study could provide evidence for the effectiveness and safety of the Zimmer Biomet Shoulder Arthroplasty systems, potentially improving treatment options for patients with shoulder conditions.

How similar studies have gone: Other studies evaluating shoulder arthroplasty systems have shown promising results, indicating that this approach is supported by prior successful research.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient must be 20 years of age or older.
* Patient must be anatomically and structurally suited to receive shoulder arthroplasty implants.
* Patient is a candidate for shoulder arthroplasty due to one or more of the following:

Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis.

Rheumatoid arthritis. Fractures of the proximal humerus, where other methods of treatment are deemed inadequate.

Difficult clinical management problems, where other method of treatment may not be suitable or may be inadequate.

* Patient must be able and willing to complete the protocol required follow-up.
* Patient must be able and willing to sign the IRB/EC approved informed consent.

Exclusion Criteria:

* Patient is unwilling or unable to give consent or to comply with the follow-up program.
* Patient has any condition which would in the judgement of the Investigator, place the patient at undue risk or interfere with the study.
* Patient is known to be pregnant or breastfeeding.
* Patient is a vulnerable subject (prisoner, mentally incompetent or unable to understand what participation to the study entails, a known alcohol or drug abuser, and/or anticipated to be non- compliant).
* Patient is uncooperative or patient with neurologic disorders who is incapable or unwilling to follow directions.
* Patient has any sign of infection affecting the shoulder joint or in its proximity which may spread to the implant site.
* Patient has rapid joint destruction, marked bone loss, or bone resorption apparent on roentgenogram.
* Patient has any neuromuscular disease compromising the affected limb that would render the procedure unjustifiable.
* Patient presents with osteoporosis, which in the opinion of the Investigator, may limit the subject's ability to support total shoulder arthroplasty using the study device.
* Patient has a metabolic disorder that may impair bone formation.
* Patient has osteomalacia.

Where it's running

  • ARCUS Kliniken Pforzheim
    Pforzheim, Germany
    Recruiting
  • Meander Medisch Centrum
    Amersfoort, Tz, Netherlands
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.